Compass Therapeutics Inc
CMPX
Market Cap$265.55M
Close$
$0.18
90.1% downside
Current Fair Value
90.1% downsideOvervalued by 90.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $265.55 Million |
|---|---|
| Enterprise Value | $235.62 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.33 |
| Beta | 0.73 |
| Outstanding Shares | 136,608,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -5.8 |
|---|---|
| PEG | -111.81 |
| Price to Sales | - |
| Price to Book Ratio | 1.78 |
| Enterprise Value to Revenue | 63.79 |
| Enterprise Value to EBIT | -4.25 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.05 |
Revenue Sources
No data
Insider Trades
ESG Score
No data